•
Sep 30, 2023

Corteva Q3 2023 Earnings Report

Corteva's third quarter results reflected a decrease in net sales and a loss from continuing operations, impacted by volume declines and strategic product exits, while price increases partially offset the declines.

Key Takeaways

Corteva reported a 7% decrease in net sales for the third quarter of 2023, with a GAAP loss from continuing operations of $315 million and a non-GAAP operating EPS of $(0.23). The sales decline was attributed to lower volumes, particularly in the Crop Protection segment, although price increases partially mitigated the impact. Management has affirmed the full-year net sales and earnings guidance.

Net sales decreased 7% versus the same period last year.

Organic sales declined 13%.

Volume declined 15% versus the prior-year period driven by strategic product exits and ongoing headwinds in the Crop Protection segment.

GAAP income from continuing operations after income taxes was a loss of $315 million.

Total Revenue
$2.59B
Previous year: $2.78B
-6.7%
EPS
-$0.23
Previous year: -$0.12
+91.7%
Gross Profit
$944M
Previous year: $898M
+5.1%
Cash and Equivalents
$2.36B
Previous year: $2.2B
+7.4%
Free Cash Flow
-$267M
Total Assets
$43.1B
Previous year: $40.7B
+6.0%

Corteva

Corteva

Corteva Revenue by Segment

Corteva Revenue by Geographic Location

Forward Guidance

Corteva expects net sales in the range of $17.0 billion to $17.3 billion, down 2% versus prior year at the mid-point. Operating EBITDA is expected to be in the range of $3.25 billion to $3.45 billion, growth of 4% at the mid-point. Operating EPS is expected to be in the range of $2.50 to $2.70 per share, down 3% at the mid-point.

Positive Outlook

  • Global agriculture outlook remains positive overall in 2023, with high demand for grain and oilseeds.
  • Commodity prices are above historical averages.
  • Farm balance sheets and income levels remain generally healthy.
  • Growers are encouraged to prioritize technology to maximize return.
  • Operating EBITDA is expected to be in the range of $3.25 billion to $3.45 billion, growth of 4% at the mid-point.

Challenges Ahead

  • Company’s outlook for its operations in Brazil has been revised, influenced by lower-than-expected corn planted area.
  • Ongoing headwinds in crop chemicals.
  • Delayed farmer purchases on both plantings and crop protection applications.
  • Elevated levels of generic products.
  • Operating EPS is expected to be in the range of $2.50 to $2.70 per share, down 3% at the mid-point.

Revenue & Expenses

Visualization of income flow from segment revenue to net income